Curis
CRIS
#10341
Rank
โ‚น1.80 B
Marketcap
โ‚น46.24
Share price
-2.08%
Change (1 day)
-73.96%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น353.55. In 2024 the company made an earnings per share (EPS) of -โ‚น677.24 an increase over its 2023 EPS that were of -โ‚น869.91.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-53.36%
2024-โ‚น677.24-22.15%
2023-โ‚น869.91-26.17%
2022-โ‚น1,17822.3%
2021-โ‚น963.35-25.37%
2020-โ‚น1,291-30.93%
2019-โ‚น1,869-2.02%
2018-โ‚น1,907
2016-โ‚น4,335-10%
2015-โ‚น4,817138.1%
2014-โ‚น2,02340%
2013-โ‚น1,445-25%
2012-โ‚น1,92766.67%
2011-โ‚น1,156

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.20-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น342.95-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.68-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น301.53-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น374.74 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,083 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น135.83-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA